Candel Therapeutics (CADL) Revenue (2020 - 2023)
Historic Revenue for Candel Therapeutics (CADL) over the last 4 years, with Q4 2023 value amounting to $4.5 million.
- Candel Therapeutics' Revenue rose 1447096.77% to $4.5 million in Q4 2023 from the same period last year, while for Dec 2023 it was $2.6 million, marking a year-over-year increase of 199274.19%. This contributed to the annual value of $2.1 million for FY2024, which is 1946.05% down from last year.
- According to the latest figures from Q4 2023, Candel Therapeutics' Revenue is $4.5 million, which was up 1447096.77% from -$669000.0 recorded in Q3 2023.
- In the past 5 years, Candel Therapeutics' Revenue registered a high of $4.5 million during Q4 2023, and its lowest value of -$669000.0 during Q3 2023.
- Moreover, its 4-year median value for Revenue was $31000.0 (2020), whereas its average is $195733.3.
- Over the last 5 years, Candel Therapeutics' Revenue had its largest YoY gain of 1447096.77% in 2023, and its largest YoY loss of 225806.45% in 2023.
- Over the past 4 years, Candel Therapeutics' Revenue (Quarter) stood at $31000.0 in 2020, then changed by 0.0% to $31000.0 in 2021, then changed by 0.0% to $31000.0 in 2022, then surged by 14470.97% to $4.5 million in 2023.
- Its Revenue was $4.5 million in Q4 2023, compared to -$669000.0 in Q3 2023 and -$644000.0 in Q2 2023.